A
Andrew G. Nicholson
Researcher at National Institutes of Health
Publications - 512
Citations - 87875
Andrew G. Nicholson is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Idiopathic pulmonary fibrosis. The author has an hindex of 113, co-authored 477 publications receiving 73860 citations. Previous affiliations of Andrew G. Nicholson include National Yang-Ming University & University College London.
Papers
More filters
Journal ArticleDOI
Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply.
David A. Lynch,Nicola Sverzellati,William D. Travis,Thomas V. Colby,Yoshikazu Inoue,Andrew G. Nicholson,Suhail Raoof,Luca Richeldi,Christopher J. Ryerson,Jay H. Ryu +9 more
Journal ArticleDOI
CYFRA 21-1 Predicts Progression in IPF: A Prospective Longitudinal Analysis of the PROFILE Cohort.
Philip L. Molyneaux,William A. Fahy,Adam J. Byrne,Rebecca Braybrooke,Peter Saunders,Richard Toshner,Gesa J. Albers,Felix Chua,Elisabetta A. Renzoni,Athol U. Wells,Yakshitha Karkera,Eunice Oballa,Gauri Saini,Andrew G. Nicholson,Gisli Jenkins,Toby M. Maher +15 more
TL;DR: CYFRA 21-1, a marker of epithelial damage and turnover, has the potential to be an important prognostic and therapeutic biomarker in individuals with IPF.
Journal ArticleDOI
P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer
Mari Mino-Kenudson,Mary W. Redman,J. Hedger,Jillian B. Daigneault,Johan Botling,E. Brambilla,Gongyan Chen,T-Y. Chou,Wendy A Cooper,Fred R. Hirsch,Deepali Jain,Keith M. Kerr,John W. Longshore,Fernando Lopez-Rios,Noriko Motoi,Giuseppe Pelosi,M. Tsao,Yasushi Yatabe,Mary Beth Beasley,Alain C. Borczuk,Lukas Bubendorf,Jin-Haeng Chung,Sanja Dacic,David H. Hwang,Yuko Minami,Andre L. Moreira,Andrew G. Nicholson,Mauro Papotti,Claudia Poleri,Natasha Rekhtman,Anja C. Roden,Prue Russell,Lynette M. Sholl,Erik Thunnissen,William D. Travis,Akihiko Yoshida,M. Wynes,I. I. Wistuba,Sylvie Lantuejoul +38 more
Journal ArticleDOI
Multiple combined sclerosing haemangiomas and tumourlets. A report of two patients with bilateral disease.
TL;DR: Meier product-limit method and log rank test, lower CB immunoreactivity appeared prognostically advantageous over more extensive reactivity when predicting disease-specific survival, but not so locoregional control or failurefree survival.
Journal ArticleDOI
MALT lymphoma arising on a background of reactive pulmonary lymphoid hyperplasia in a patient with systemic lupus erythematosus
TL;DR: A case of pulmonary non-Hodgkin lymphoma of MALT origin arising on a background RPLH with coexistent amyloidosis is presented, confirmed by immunohistochemical and clonality studies.